Sponsor:
Eli Lilly and Company
Code:
NCT07867327
Conditions
Healthy
Eligibility Criteria
Sex: Male
Age: 18 - 55
Healthy Volunteers: Accepted
Interventions
[¹⁴C]-LY4515100 Oral Solution
LY4515100 Tablet
[¹⁴C]-LY4515100 IV
Brief summary:
Conditions
Healthy
Study ID
NCT07867327
Start date
Oct 14, 2026
Status verified date
Nov, 2026
Completion date
Dec, 2026
Anticipated
Primary completion date
Dec, 2026
Anticipated
Eligibility Criteria
Sex: Male
Age: 18 - 55
Healthy Volunteers: Accepted
Enrollment
16 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Basic Science
Arms
experimental: [¹⁴C]-LY4515100 Part 1
experimental: LY4515100 + [¹⁴C]-LY4515100 Part 2
Interventions
[¹⁴C]-LY4515100 Oral Solution
LY4515100 Tablet
[¹⁴C]-LY4515100 IV
Primary outcome measure
Central contacts
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
1-317-615-4559LillyTrials@Lilly.comPhysicians interested in becoming principal investigators please contact
clinical_inquiry_hub@lilly.comLocations
Fortrea Clinical Research Unit
Recruiting
Madison, Wisconsin, United States, 53704
Contacts
Principal Investigator:
Kimberly Cruz
Sponsor
Eli Lilly and Company
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.